Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) - PubMed (original) (raw)

Guideline

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 2001.

No abstract available

PubMed Disclaimer

Comment in

• Updated guidelines for cholesterol management.
  Lauer MS, Fontanarosa PB. Lauer MS, et al. JAMA. 2001 May 16;285(19):2508-9. doi: 10.1001/jama.285.19.2508. JAMA. 2001. PMID: 11368705 No abstract available.
• Atorvastatin for acute coronary syndromes.
  Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR. Schwartz GG, et al. JAMA. 2001 Aug 1;286(5):533-5. JAMA. 2001. PMID: 11476650 No abstract available.
• Guidelines for diagnosis and treatment of high cholesterol.
  Feeman WE Jr. Feeman WE Jr. JAMA. 2001 Nov 21;286(19):2400; author reply 2401-2. JAMA. 2001. PMID: 11712927 No abstract available.
• Guidelines for diagnosis and treatment of high cholesterol.
  Caldwell LR. Caldwell LR. JAMA. 2001 Nov 21;286(19):2400; author reply 2401-2. JAMA. 2001. PMID: 11712928 No abstract available.
• Guidelines for diagnosis and treatment of high cholesterol.
  Iliff D. Iliff D. JAMA. 2001 Nov 21;286(19):2400-1; author reply 2401-2. JAMA. 2001. PMID: 11712929 No abstract available.
• Guidelines for diagnosis and treatment of high cholesterol.
  Rosch PJ. Rosch PJ. JAMA. 2001 Nov 21;286(19):2401; author reply 2401-2. JAMA. 2001. PMID: 11712930 No abstract available.
• Guidelines for diagnosis and treatment of high cholesterol.
  Ring BL. Ring BL. JAMA. 2001 Nov 21;286(19):2401-2. JAMA. 2001. PMID: 11712931 No abstract available.
• Reducing the risk of stroke.
  Lakshminarayan K, Anderson DC. Lakshminarayan K, et al. JAMA. 2003 Apr 16;289(15):1928; author reply 1929. doi: 10.1001/jama.289.15.1928-a. JAMA. 2003. PMID: 12697793 No abstract available.

Similar articles

• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
  National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation. 2002 Dec 17;106(25):3143-421. Circulation. 2002. PMID: 12485966 No abstract available.
• The heart of the matter. National guidelines urge more aggressive cholesterol treatment.
  Leake NB. Leake NB. Adv Nurse Pract. 2002 Jan;10(1):42-7; quiz 48-9. Adv Nurse Pract. 2002. PMID: 12420511 No abstract available.
• Update on managing hypercholesterolemia. The new NCEP guidelines.
  Kuhar MB. Kuhar MB. AAOHN J. 2002 Aug;50(8):360-4. AAOHN J. 2002. PMID: 12227210
• Impact of the new National Cholesterol Education Program (NCEP) guidelines on patient management.
  Harmel AP, Berra K. Harmel AP, et al. J Am Acad Nurse Pract. 2003 Aug;15(8):350-60. doi: 10.1111/j.1745-7599.2003.tb00408.x. J Am Acad Nurse Pract. 2003. PMID: 14509100 Review.
• An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
  Ansell BJ, Watson KE, Fogelman AM. Ansell BJ, et al. JAMA. 1999 Dec 1;282(21):2051-7. doi: 10.1001/jama.282.21.2051. JAMA. 1999. PMID: 10591388 Review.

Cited by

• Influence of Common Gene Variants on Lipid Levels and Risk of Coronary Heart Disease in Afro-Caribbeans.
  Larifla L, Bassien-Capsa V, Velayoudom FL, Chingan-Martino V, Afassinou Y, Ancedy Y, Galantine O, Galantine V, Nicolas L, Martino F, Numeric P, Foucan L, Humphries SE. Larifla L, et al. Int J Mol Sci. 2024 Oct 17;25(20):11140. doi: 10.3390/ijms252011140. Int J Mol Sci. 2024. PMID: 39456920 Free PMC article.
• Cardiovascular risk and midlife cognitive decline in the Study of Women's Health Across the Nation.
  Derby CA, Hutchins F, Greendale GA, Matthews KA, Sternfeld B, Everson-Rose SA, Kazlauskaite R, Whitmer RA, Brooks MM. Derby CA, et al. Alzheimers Dement. 2021 Aug;17(8):1342-1352. doi: 10.1002/alz.12300. Epub 2021 Mar 12. Alzheimers Dement. 2021. PMID: 33710770 Free PMC article.
• Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver.
  Lehmann R, Franken H, Dammeier S, Rosenbaum L, Kantartzis K, Peter A, Zell A, Adam P, Li J, Xu G, Königsrainer A, Machann J, Schick F, Hrabé de Angelis M, Schwab M, Staiger H, Schleicher E, Gastaldelli A, Fritsche A, Häring HU, Stefan N. Lehmann R, et al. Diabetes Care. 2013 Aug;36(8):2331-8. doi: 10.2337/dc12-1760. Epub 2013 Mar 20. Diabetes Care. 2013. PMID: 23514731 Free PMC article.
• Cardiovascular Risk Estimates in Ten Years in the Brazilian Population, a Population-Based Study.
  Malta DC, Pinheiro PC, Teixeira RA, Machado IE, Santos FMD, Ribeiro ALP. Malta DC, et al. Arq Bras Cardiol. 2021 Mar;116(3):423-431. doi: 10.36660/abc.20190861. Arq Bras Cardiol. 2021. PMID: 33909770 Free PMC article. English, Portuguese.
• Oxidant/antioxidant status in Type-2 diabetes mellitus patients with metabolic syndrome.
  Najafi A, Pourfarzam M, Zadhoush F. Najafi A, et al. J Res Med Sci. 2021 Jan 28;26:6. doi: 10.4103/jrms.JRMS_249_20. eCollection 2021. J Res Med Sci. 2021. PMID: 34084185 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information